Andhra Pradesh-based diversified chemicals-and-agro manufacturer: caustic soda, sulphuric acid and other chlor-alkali products, bulk drugs (Aspirin, Salicylic Acid), sugar, and captive power generation.
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 983 | 1.1k | 1.2k | 1.3k | 1.3k | 1.3k | 1.6k | 1.4k |
| Borrowings | 254 | 157 | 51 | 22 | 25 | 13 | 7 | 1 |
| Other Liabilities | 259 | 278 | 322 | 329 | 301 | 325 | 491 | 318 |
| Total Liabilities | 1.5k | 1.6k | 1.6k | 1.6k | 1.6k | 1.7k | 2.1k | 1.7k |
| AssetsFixed Assets | 662 | 668 | 665 | 762 | 772 | 916 | 951 | 890 |
| CWIP | 28 | 46 | 68 | 125 | 180 | 49 | 46 | 42 |
| Investments | 228 | 287 | 275 | 142 | 137 | 157 | 413 | 358 |
| Other Assets | 605 | 556 | 638 | 610 | 551 | 550 | 725 | 441 |
| Total Assets | 1.5k | 1.6k | 1.6k | 1.6k | 1.6k | 1.7k | 2.1k | 1.7k |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 123 | 184 | 233 | 197 | 249 | 128 | 118 | 277 |
| Cash from Investing | -145 | -25 | -115 | -44 | -177 | -102 | -90 | -234 |
| Cash from Financing | 26 | -166 | -122 | -149 | -87 | -25 | -28 | -27 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 62 | 138 | 151 | 107 | 34 | -3 | 31 | 226 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (20.8×) and current (13.4×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At -23.2% growth and a 13× exit, ₹83 only delivers your return if you pay ₹8. The price is currently baking in 18% growth.
EPS grows -23.2%/yr for 5 years, then fades to 6% over 2, exits at 13×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | -23.2% | 4.75 |
| FY28 | -23.2% | 3.65 |
| FY29 | -23.2% | 2.80 |
| FY30 | -23.2% | 2.15 |
| FY31 | -23.2% | 1.65 |
| FY32 | -8.6% ·fade | 1.51 |
| FY33 | 6.0% ·fade | 1.60 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.